Neurofibromatoses: Clinical Trials

1 trial for Neurofibromatoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Neurofibromatoses: new trials by email Literature Review of Neurofibromatoses trials Research Report on Neurofibromatoses

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas
Erbium-YAG laser vaporization - Cutaneous Neurofibromas
Phase 2 / Phase 3UnknownMedical University of Vienna122006-04-012011-07-13

Narrower conditions

Neurofibromatosis 1 (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplastic Syndromes, Hereditary (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)  ·  Neurocutaneous Syndromes (1)  ·  Neurodegenerative Diseases (1)  ·  Neurofibroma (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)

Sponsors

Medical University of Vienna (1)

Countries

Austria (1)

Top investigators

Wolfgang Happak, Prof. MD (1)